Glucagon is secreted by the pancreatic alpha cell population in situations of hypoglycemia or stress, reaching blood concentrations of up to 1 ng/mL in such situations
Other potential risks include pancreatitis (rare but serious), gallbladder disease (including cholecystitis and cholelithiasis), and hypoglycaemia when used in combination with insulin or sulfonylureas
The allegations, which are drawn from interviews with former employees, legal filings in court cases between Empower and former employees, FDA inspection reports and warning letters, and documents from state boards of pharmacy, show a dark side of the exploding market for GLP-1 weight loss shots and other drugs made by compounders
An updated report by the American Society of Anesthesiologists task force on preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration
[Accessed 20 January 2026] Water, drinks and your health